Logo
Login Sign Up
Current Revision

ISO 18362:2016

Manufacture of cell-based health care products - Control of microbial risks during processing
Best Price Guarantee
Instant

$200.97

2-5 Days

$200.97

SAVE 15%

$341.65

Modifications (Amendments, Corrigenda, Errata, etc.)

$23.10

$23.10

$39.27


Sub Total (1 Item(s))

$ 0.00

Estimated Shipping

$ 0.00

Total (Pre-Tax)

$ 0.00


View in Library
or
International Organization for Standardization Logo

ISO 18362:2016

Manufacture of cell-based health care products - Control of microbial risks during processing

PUBLISH DATE 2016
ISO 18362:2016

ISO 18362:2016 specifies the minimum requirements for, and provides guidance on, a risk-based approach for the processing of cell-based health care products (CBHPs) requiring control of viable and non-viable microbial contamination. It is applicable both to CBHPs labelled 'sterile' and to CBHPs not labelled 'sterile'.

ISO 18362:2016 is not applicable to:

  • procurement and transport of cell-based starting material used in processing of a CBHP,
  • cell banking,
  • control of genetic material,
  • control of non-microbial product contamination,
  • in vitro diagnostics (IVDs), or
  • natural medicines.

EXAMPLE Vitamins and minerals, herbal remedies, homoeopathic medicines, traditional medicines such as traditional Chinese medicines, probiotics, other products such as amino acids and essential fatty acids.

ISO 18362:2016 does not define biosafety containment requirements.

ISO 18362:2016 does not replace national or regional regulations that apply to the manufacture and quality control of a CBHP.

SDO ISO: International Organization for Standardization
Document Number ISO 18362
Publication Date Feb. 1, 2016
Language en - English
Page Count
Revision Level
Supercedes
Committee ISO/TC 198
Loading...

Failed to load document history.

Publish Date Document Id Type View